Patents by Inventor Hermanus L. Jooste

Hermanus L. Jooste has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091239
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 21, 2024
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Patent number: 11844804
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: December 19, 2023
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Publication number: 20230390187
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: August 21, 2023
    Publication date: December 7, 2023
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Patent number: 11771646
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: October 2, 2020
    Date of Patent: October 3, 2023
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Publication number: 20210137944
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 13, 2021
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Patent number: 10912782
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: February 9, 2021
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Publication number: 20210015741
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: October 2, 2020
    Publication date: January 21, 2021
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Patent number: 10821072
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: November 3, 2020
    Assignee: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Publication number: 20190224215
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: February 1, 2019
    Publication date: July 25, 2019
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
  • Patent number: 10238662
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: March 26, 2019
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Hermanus L. Jooste, Kaushik J. Dave, Jon Jaffe
  • Publication number: 20190030260
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: October 1, 2018
    Publication date: January 31, 2019
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Patent number: 9950125
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: April 24, 2018
    Assignee: ANTARES PHARMA, INC.
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Publication number: 20170043103
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: August 17, 2016
    Publication date: February 16, 2017
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe
  • Publication number: 20170007621
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: February 19, 2015
    Publication date: January 12, 2017
    Applicant: Antares Pharma, Inc.
    Inventors: Paul K. WOTTON, Hermanus L. JOOSTE, Kaushik J. DAVE, Jon JAFFE
  • Publication number: 20150297600
    Abstract: Determining that a patient in need of methotrexate requires more systemically available methotrexate than can be obtained by an orally administered dose of methotrexate; and subcutaneously administering a dose of methotrexate to the patient.
    Type: Application
    Filed: April 16, 2015
    Publication date: October 22, 2015
    Inventors: Peter L. SADOWSKI, Kaushik J. DAVE, Paul K. WOTTON, Hermanus L. JOOSTE
  • Publication number: 20130303985
    Abstract: The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
    Type: Application
    Filed: April 5, 2013
    Publication date: November 14, 2013
    Inventors: Paul K. Wotton, Kaushik J. Dave, John W. Hayes, Peter L. Sadowski, Hermanus L. Jooste, Jonathan Jaffe